Profil
Pascal Birman is currently the Chief Medical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, he worked as the Medical Director at Pherecydes Pharma SA and as the Deputy Chief Medical Officer at Genfit SA.
Postes actifs de Pascal Birman
| Sociétés | Poste | Début |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 23/06/2023 |
Anciens postes connus de Pascal Birman
| Sociétés | Poste | Fin |
|---|---|---|
| GENFIT | Corporate Officer/Principal | - |
| PHERECYDES PHARMA | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENFIT | Health Technology |
| PHAXIAM THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
